2021 American Transplant Congress
Recurrence and Outcome of Anti-GBM Glomerulonephritis After Kidney Transplantation: A Belgian Multicenter Study
Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
*Purpose: Recurrence of anti-glomerular basement membrane (anti-GBM) glomerulonephritis (GN) in the kidney graft is a rare event, described in limited case reports and registry analysis.…2021 American Transplant Congress
Kidney Transplantation in Very Highly-Sensitized Patients with Maastricht Type III Non-heart-Beating Donors
*Purpose: In 2012, a kidney transplant (KT) program for very highly-sensitized (VHS) patients (PRA ≥ 95%) based on virtual crossmatch began in Andalusia (Spanish region).…2021 American Transplant Congress
Risk Stratification of Kidney Transplant Patients According to the Different Level of HLA-DQ Disparities
*Purpose: It is becoming clear that de novo donor-specific antibodies (dnDSA) against HLA-DQ are the most prevalent and the leading cause of chronic antibody-mediated rejection…2021 American Transplant Congress
HLA Mismatching and Subclinical Inflammation: An Association to be Considered in Kidney Transplant Patients with Low Immunological Risk
*Purpose: Subclinical inflammation (SCI) (2021 American Transplant Congress
Prolonged Cold Ischemic Time Demonstrating Minor Effect on Outcomes Following Renal Transplantation – A Paired Kidney Analysis
1Columbia University Irving Medical Center, New York, NY, 2Columbia University, New York, NY
*Purpose: An improved understanding of the effects of cold ischemia time (CIT) on deceased donor kidney (DDK) outcomes may increase organ utilization by clarifying the…2021 American Transplant Congress
Early Portal Vein Ligation in the Setting of Shorter Hepatectomy May Contribute to Better Surgical Outcomes in Deceased Donor Liver Transplantation
Henry Ford Hosptial, Detroit, MI
*Purpose: Few published reports have suggested lower blood loss in association with early portal vein ligation (e-PVL) during liver transplantation surgery, however there are currently…2021 American Transplant Congress
Re-Do Hepatic Artery Reconstruction for Thrombosis Can Save Grafts and Patients without Retransplantation: Lessons Learned from 1,355Adult Living Donor Liver Transplantations
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Hepatic artery thrombosis (HAT) after liver transplantation is associated with a marked increase in morbidity, being the main cause of graft loss and bile…2021 American Transplant Congress
High Levels of Donor-Derived Cell-Free DNA Predict EGFR Decline After Kidney Transplantation
*Purpose: Persistent, low-grade inflammation is associated with decline in eGFR. Cross-sectional studies have demonstrated a consistent association between circulating inflammatory markers and kidney function. Our…2021 American Transplant Congress
LacripepTM-like Peptide N-104 Increases Insulin Secretion and Promotes Islet Transplantation Outcomes
University of Virginia Health System, Charlottesville, VA
*Purpose: To study if LacripepTM-like peptide N-104 promotes beta-cell stabilization and islet transplantation outcomes. Background: Lacritin is a multifunctional tear protein with prosecretory, prosurvival and…2021 American Transplant Congress
Outcomes After Usage of Organs from Deceased Organ Donors with Sepsis – A Single-center Experience
*Purpose: The deceased Organ Donation rate is around 0.8/million in our nation. There remains a severe shortage of organs worldwide, leading to a trend towards…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 113
- Next Page »